Crispene E, a cis-clerodane diterpene inhibits STAT3 dimerization in breast cancer cells.

Julia Mantaj,S. M. Abdur Rahman,B. Bokshi,Choudhury M. Hasan,Paul J. M. Jackson,Richard B. Parsons,Khondaker M. Rahman
DOI: https://doi.org/10.1039/c5ob00052a
2015-03-18
Abstract:Crispene E, a new clerodane-type diterpene, inhibited STAT3 dimerization in a cell-free fluorescent polarisation assay and was found to have significant toxicity against STAT3-dependent MDA-MB 231 breast cancer cell line and selectively inhibited the expression of STAT3 and STAT3 target genes cyclin D1, Fascin and bcl-2. Molecular docking studies suggest the molecule inhibits STAT3 by interacting with its SH2 domain. The compound has been isolated from Tinospora crispa and characterized using standard spectroscopic techniques.
What problem does this paper attempt to address?